Confirmed Speakers

Tomas Büchler Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Czech Republic
Sergi Castellví-Bel Institut d’Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Hospital Clínic, Barcelona, Spain
Jianfeng  Chen Fudan University Shanghai Cancer Center, Shanghai, China
Richarda DeVoer Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands
Beatrice Mohelníková Duchoňová Deputy head of the Oncology Clinic of the University Hospital Olomouc, Czech Republic
Asta Försti Hopp Children's Cancer Center, Heidelberg, and Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany
Yael Goldberg Raphael Recanati Genetics Institute, Beilinson Hospital, Rabin Medical Center, Petach Tikva, Israel
Kari Hemminki Era Chair Holder at the Faculty of Medicine in Pilsen, Charles University, Head of the Laboratory of Translational Cancer Genomics, Czech Republic
Richard Houlston Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom
David Hughes UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland
Víctor Moreno Head of Oncology Result Unit, Insitute Catala d´Oncologia, Universitat de Barcelona, Spain
Alessio Naccarati Molecular Genetics Epidemiology Unit, Italian Institute for Genomic Medicine, c/o IRCCS Candiolo, Turin, Italy
Claire Palles Institute of Cancer and Genomic Sciences, Institute of Biomedical Research, University of Birmingham, Birmingham, United Kingdom
Barbara Pardini Molecular Genetics Epidemiology Unit, Italian Institute for Genomic Medicine, c/o IRCCS Candiolo, Turin, Italy
Ulrike Peters Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Regine Schneider-Stock Institute of Pathology, University Hospital Erlangen, Erlangen, Germany
Ondřej Slabý Head of the Biological Institute, Masaryk Memorial Cancer Institute, Brno, Czech Republic
Pavel Souček Head of the laboratory of Pharmacogenomics, Faculty of Medicine in Pilsen, Charles University, Czech Republic
Fredrik Jan van Schooten Department of Genetic and Molecular Toxicology, Maastricht University, Maastricht, Netherlands
Pavel Vodička  Head of the Department of the Molecular Biology of Cancer of the Institute of Experimental Medicine CAS, Czech Republic